Search Results
165 items found for "Jong-Chan Park"
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
immunohistochemistry; JAK1: Janus kinase 1; LOX: lysyl oxidase; MAP1LC3B/LC3: microtubule associated protein 1 light chain
- 📰 GPCR Weekly News, April 1 to 7, 2024
If you have any research you would like to showcase to our community, you can submit a poster presentation It doesn’t have to be a complete poster, just a few slides to spark the conversation. Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook Sosei Heptares officially changed
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers class B GPCRs, however, has been more controversial, despite increasing evidence that these receptors can These dimeric forms, which can either be transient or stable, are believed to influence the function Recent studies suggest that class B1 GPCRs can form both homodimers and heterodimers, which may play Graaf, C., et al., Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March
- 📰 GPCR Weekly News, December 18 to 31, 2023
GPCR Ecosystem group, where you can find Dr. GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go application of optogenetically functionalized Drosophila dopamine receptors Targeting CB2R in astrocytes for Parkinson's Updates in GPCR Research Direct Binding Methods to Measure Receptor-Ligand Interactions How accurately can
- 📰 GPCR Weekly News, December 11 to 17, 2023
GPCR Ecosystem group, where you can find Dr. GPCR Ecosystem contents and perks, including our forums, private groups, and all Ecosystem members Go Meaningful Proof-of-Concept Data From Phase 2a Clinical Study Neurocrine opening two Phase 1 trials in oral Parkinson
- Therapeutic validation of an orphan G protein‐coupled receptor
., 2011), although it is widely accepted that medium‐chain fatty acids (MCFAs) can bind to and activate and 2. which ligands can be used as tool compounds to study the function and biology of this receptor distinct functional outcomes of agonist ligands (Pillaiyar et al., 2018) with biased properties which can
- 📰 GPCR Weekly News, September 25 to October 1, 2023
Unfortunately, registration has closed, but you can still join the waitlist by emailing gpcrretreat@uottawa.ca You can submit your logo design by November 1st, and registration is unnecessary to participate. You can find all the necessary information on the Logo Contest page. Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- 📰 GPCR Weekly News, September 18 to 24, 2023
If you couldn't make it, no sweat – our premium members can always go back and watch the recorded talks Registration is now closed, but you can join the waitlist by emailing gpcrretreat@uottawa.ca. Novo Nordisk's North Carolina semaglutide plant Excellerate Bioscience Announces Site Relocation AI can Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Don't miss out on this chance to elevate your knowledge and skills in pharmacology! Allow registrants to appreciate the incredible versatility of GPCRs and how small molecules can affect
- 📰 GPCR Weekly News, November 13 to 19, 2023
cannabidiol, on the cannabinoid CB2 receptor GPCRs in Cardiology, Endocrinology, and Taste Transcriptomic changes
- 📰 GPCR Weekly News, March 13 to 19, 2023
Remember, you can always adjust your email preferences in your account settings. For Dr. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that we can add it to the list of posters and increase the number of people who can ''stop by'' it tomorrow GPCRs in Neuroscience Physiological Condition-Dependent Changes in Ciliary GPCR Localization in the Brain
- 📰 GPCR Weekly News, June 17 to 23, 2024
mechanotransduction at endothelial junctions GPCRs in Neuroscience Male-specific behavioral and transcriptomic changes Peptidase M84 from Bacillusaltitudinis induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR Epilepsy Models Biophysicists decipher functionality of adrenaline-binding receptor Tectonic plates more than
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
the G protein-coupled A2A adenosine receptor (A2AAR) have been considered promising agents to treat Parkinson's simultaneously interact with both Ser2777.42 and His2787.43, 2 only transiently contacts His2787.43, which can This approach can expand the repertoire of adenosine receptor antagonists that can be designed based
- Regulators of G-protein signaling: essential players in GPCR signaling
Upon activation, GPCRs have conformational changes that allow the coupling and subsequent activation Liu-Chen, and J.R.
- Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases
neuropsychiatric diseases including Amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, Parkinson's
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
trigger receptor internalization via interaction with the adaptor protein 2 (AP2) and clathrin heavy chain Lipid molecules, such as phosphoinositides, can bind to specific domains of β-arrestins, promoting their Therefore the lipid composition of the bilayer can influence the kinetics and efficiency of β-arrestin
- Targeting Intracellular Allosteric Sites in GPCRs
These sites act as molecular switches that can modulate receptor activity, providing an untapped opportunity and NAMs and thereby blocks the effects of positive and negative allosteric modulators (Rodriguez, Nong : 1) affinity modulation where the resulting change in conformation can influence the orthosteric binding Moreover, they have the potential to enhance target selectivity, which can arise from greater sequence Allosteric agonists binding to intracellular sites can also promote G-protein signaling.
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Premium members can enjoy a 25% OFF early bird discount , but hurry - it's only available for a limited Don’t miss this chance to benefit from our early bird pricing and premium content. Degradation Modalities A quick revision of how β-adrenergic receptors work and how their antagonists can
- Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with ...
nervous system and neurologic disorders, particularly movement disorders like dyskinesia associated with Parkinson's
- Adhesion GPCR Consortium Newsletter - May 2024
If I wanted to be part of the narrative, I felt that I had to join the community. And so I did. A reminder of how fragile civilizations can be. What is your favorite taco? What mariachi song are you most likely to shout along to at 3 AM? The way it is served with swiftly chopped charred pineapple for garnish adds to the visuals. Mariachi song: I typically do not sing to these since they are dear to Mexican childhood memories, and
- In Vitro and In Silico Characterization of Kurarinone as a Dopamine D 1A Receptor Antagonist and ...
Since studies have indicated that flavonoids can target brain GPCRs and provide neuroprotection via inhibition appreciable D2LR and D4R agonism and D1R antagonism, kurarinone might be a potential compound that can alleviate clinical symptoms of Parkinson's disease and other NDDs.
- Overview of adhesion GPCRs self-activation
Structurally they characterize by a long extracellular region of adhesion-like domains which modulate Through cell-based assays and Cryo-EM of high quality, it was possible to know that ADGRL3 can activate each G protein with the receptor showed that there are more polar interactions in Gq/Gs engagements than In view of the above, these new findings clearly demonstrate part of the molecular mechanisms involved ., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
with CCR2, indicating that β-arrestin regulates scavenging and signaling of CCR1 to a greater extent than 2000), becoming incapable of promoting cell migration, a phenomenon which is likely to be mediated by changes
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
Artificial intelligence - Machine learning vs Deep Learning GPCRs have long been recognized as important Mutations: ML methods can determine stabilising mutations that enable structure determination and can predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong , 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5. ability of a ligand to induce or inhibit a cellular response (pEC50 or pIC50, respectively), and how long
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
However only ~15% of the GPCR superfamily has been successfully drugged, due in part to the intractability Small protein GPCRs feature a two-component binding mechanism in which one part of the ligand engages The other part of the ligand reaches in to contact the TM domain of the receptor, providing a ‘message extensively explored by using surface display technology, with molecular diversity focused into the part This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that